Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Metronidazole
Sanofi-Aventis Ireland Limited T/A SANOFI
P01AB01
Metronidazole
400 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
metronidazole
Marketed
1977-04-01
PACKAGE LEAFLET: INFORMATION FOR THE USER FLAGYL TM 200MG TABLETS FLAGYL TM 400MG TABLETS Metronidazole Is this leaflet hard to see or read? Phone 01 403 5600 for help READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If any side effects get serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. See section 4. WHAT IS IN THIS LEAFLET: 1. What Flagyl is and what it is used for 2. What you need to know before you take Flagyl 3. How to take Flagyl 4. Possible side effects 5. How to store Flagyl 6. Contents of the pack and other information 1. WHAT FLAGYL IS AND WHAT IT IS USED FOR Flagyl belongs to a group of medicines called anti-microbials. Flagyl is used in the treatment and prevention of severe infections that are caused by anaerobic bacteria, particularly species of _Bacteroides, _ anaerobic _ Streptococci, Fusobacteria, Clostridia, _ etc It works by killing bacteria and parasites that cause infections in your body. It can be used to: • Treat infections of the blood, brain, lung, bones, genital tract, pelvic area, stomach and intestines. • Treat gum ulcers and other dental infections. • Treat infected leg ulcers and pressure sores. • Prevent infections after surgery. • In the prevention and treatment of infections due to anaerobic bacteria (bacteria that are able to survive in the absence of oxygen) If you need any further information on your illness, speak to your doctor. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FLAGYL DO NOT TAKE FLAGYL: • If you are allergic (hypersensitive) to metronidazole or any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction inc Read the complete document
Health Products Regulatory Authority 18 April 2023 CRN00DC7J Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Flagyl 400mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 400 mg of metronidazole. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film coated tablet. White to off-white biconvex, capsule-shaped film-coated tablet imprinted ‘Flagyl 400’, plain reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Metronidazole is indicated in adults and children for the following indications: In the treatment of urogenital trichomoniasis In the treatment of acute ulcerative gingivitis. In the treatment of infections due to E. histolytica (including carrier states). In the treatment of infections due to G. Lamblia (including carrier states). In the prevention and treatment of infections due to anaerobic bacteria, particularly species of Bacteroides, anaerobic streptococci, fusobacteria, clostridia, etc. In the treatment of acute dental infections. In the treatment of non-specific vaginitis. Metronidazole is indicated in adults only for the following indications: In the treatment of chronic pressure sores and ulcers with possible infection due to anaerobes. _Consideration should be given to official guidance on the appropriate use of antibacterial agents._ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral Recommended Dosages: UROGENTIAL TRICHOMONIASIS Adults and children over 10 years: 2000 mg as a single dose or 200 mg 3 times daily for 7 days or 400 mg twice daily for 5 – 7 days Children <10 years: 40 mg/kg orally as a single dose or 15 – 30 mg/kg/day divided in 2 – 3 doses for 7 days; not to exceed 2000 mg/dose ACUTE ULCERATIVE GINGIVITIS Adults and children over 10 years: 600 mg daily in 3 divided doses for 3 days. Paediatric population: Health Products Regulatory Authority 18 April 2023 CRN00DC7J Page 2 of 7 _Aged 7 to 10 years: _300 mg daily in 3 divided doses for 3 days. _Aged 3 to 7 years: _200 Read the complete document